Why the study?
Changes in cardiac remodeling features profoundly affect patient outcomes, and rapid, automated assessment of LV structure and function without manual measurements is needed.
Can machine-learning models using cardiac ultrasonic textural features (ultrasomics) accurately assess left ventricular remodeling and predict major adverse cardiovascular events?
Cohort (n=1,915)
Yes
Can machine-learning models using cardiac ultrasonic textural features (ultrasomics) accurately assess left ventricular remodeling and predict major adverse cardiovascular events?
Hazard Ratio: 8.53 (95% CI 4.75–32.1)
p-value: p=0.0003
Cardiac ultrasomics-based machine learning models can accurately predict left ventricular remodeling and independently predict major adverse cardiovascular events without requiring manual measurements.
BACKGROUND Changes in cardiac size, myocardial mass, cardiomyocyte appearance, and, ultimately, the function of the entire organ are interrelated features of cardiac remodeling that profoundly affect patient outcomes. OBJECTIVES This study proposes that the application of radiomics for extracting cardiac ultrasonic textural features (ultrasomics) can aid rapid, automated assessment of left ventricular (LV) structure and function without requiring manual measurements. METHODS This study developed machine-learning models using cardiac ultrasound images from 1,915 subjects in 3 clinical cohorts: 1) an expert-annotated cardiac point-of-care-ultrasound (POCUS) registry (n = 943, 80% training/testing and 20% internal validation); 2) a prospective POCUS cohort for external validation (n = 275); and 3) a prospective external validation on high-end ultrasound systems (n = 484). In a type 2 diabetes murine model, echocardiography of wild-type (n = 10) and Leptr-/- (n = 8) mice were assessed longitudinally at 3 and 25 weeks, and ultrasomics features were correlated with histopathological features of hypertrophy. RESULTS The ultrasomics model predicted LV remodeling in the POCUS and high-end ultrasound external validation studies (area under the curve: 0.78 [95% CI: 0.68-0.88] and 0.79 [95% CI: 0.73-0.86], respectively). Similarly, the ultrasomics model predicted LV remodeling was significantly associated with major adverse cardiovascular events in both cohorts (P < 0.0001 and P = 0.0008, respectively). Moreover, on multivariate analysis, the ultrasomics probability score was an independent echocardiographic predictor of major adverse cardiovascular events in the high-end ultrasound cohort (HR: 8.53; 95% CI: 4.75-32.1; P = 0.0003). In the murine model, cardiomyocyte hypertrophy positively correlated with 2 ultrasomics biomarkers (R2 = 0.57 and 0.52, Q < 0.05). CONCLUSIONS Cardiac ultrasomics-based biomarkers may aid development of machine-learning models that provide an expert-level assessment of LV structure and function.
No takes yet. Share an insight, caveat, or question.
Hathaway et al. (2022) conducted a cohort in Cardiac remodeling and dysfunction (n=1,915). Ultrasomics probability score was evaluated on Major adverse cardiovascular events (HR 8.53, 95% CI 4.75-32.1, p=0.0003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: